摘要
目的探讨收缩性心力衰竭(Systolic heart failure,SHF)患者血浆Apelin-12水平的变化及临床意义。方法选择2010年1月~2010年6月徐州市中心医院心内科住院的慢性收缩性心力衰竭患者60例(A组),选同期体检中心心功能正常者60例作为对照组(B组)。采用酶联免疫吸附法(ELIS测定血浆Apelin-12水平。结果收缩性心力衰竭患者(A组)血浆Apelin-12水平明显低于健康对照者(B组),且差异具有统计学意义(P<0.05)。结论 Apelin-APJ系统在收缩性心力衰竭病理生理发展过程中起到重要的调节作用。
Objective To explore the change and clinical value of plasma apelin-12 in systolic heart failure patients. Methods A total of 60 patients with chronic systolic heart failure from January 2010 to June 2010 at the cardiamedical department of Xuzhou Central Hospital were involved in Group A. Another 60 healthy person with normal cardiac function were selected as control group (Group B). The levels of plasma apelin-12 were measured by enzyme linked immunoassys (ELISA) in all subjects. Results The levels of plasma apelin-12 in SHF patients(Group A) were significantly lower than those in control group(Group B) (P〈0.05).Conclusion The levels of plasma apelin-12 were decreased in SHF patients, which showed apelin-APJ system played an important role in the pathophysiological process of systolic heart failure.
出处
《当代医学》
2011年第32期74-75,共2页
Contemporary Medicine